Emmanuelle Vidal-Petiot

Physiologist and hypertension specialist
@APHP, Bichat hospital, Paris, France @univ_paris_cite

[Ph.Gabriel Steg @gabrielsteg]

86% of subjects are not abnormal !

New Definition of Elevated Blood Pressure in the 2024 ESC Guidelines: Increased Prevalence, Uncertain Evidence
our piece published today in Circulation https://t.co/yIrFhwXjwu #hypertension #prevention @EmmaVP5

[Emmanuelle Vidal-Petiot @EmmaVP5]

@dguerrot @LMarilucy @sfhta @com_SFNDT @Sautenet 🙏 venant du grand pédagogue de la néphro, quel honneur !

[Société de Physiologie et de Biologie Intégrative @SocPhysBioInt]

🚨 #JobAlert
Assistant spécialiste aux Explorations Fonctionnelles Rénales @hopitalbichat dès novembre 2024
👉 DFG, exploration des troubles phosphocalciques, hydro-électrolytiques...
👉 HTA (IIR et résistante, centre d'Excellence Européen)
👉 Infos et contact: DM @EmmaVP5

[AJKD @AJKDonline]

This Core Curriculum by Susan L. Murray and Myles Wolf reviews the physiology and pathophysiology of calcium and phosphate disorders through a series of cases, including clinical conundrums commonly encountered by nephrologists:

https://t.co/NOOYpWruzk (FREE)

@DukeKidney

[ASN Publications @asnpublications]

Hypertension is an risk factor for coronary events, stroke, heart failure, and ESKD. This study found the effects of intensive systolic BP lowering on cardiovascular end points and mortality in SPRINT were independent of time-varying diuretics use https://t.co/b4Ju6NRGs5

[JASN_News @JASN_News]

Testing for 385 genes among 1623 CKD patients identified variants in 20.8%, half of whom had new or changed diagnosis, 90.7% change in management, and 32.9% change in treatment https://t.co/vQznhjJRec

@ndahl48 @HilaMilo @fouadchebib @MayoClinicNeph @ColumbiaKidney

[Wanpen Vongpatanasin @DrWanpen]

SPRINT trial is now validated by ESPRIT RCT from China in high risk HTN including DM pts. Lowering SBP <120 compared with <140 reduces MACE by 12% , CVD death by 39%, all cause death by 21% #AHA23 🎉

[Journal of Clinical Investigation @jclinicalinvest]

Dietary potassium stimulates Ppp1Ca-Ppp1r1a dephosphorylation of kidney NaCl cotransporter and reduces blood pressure: https://t.co/by5bVHa0d2
@PAWellingMD @HopkinsMedicine
#Nephrology

[Hypertension @HyperAHA]

Unilaterally Selective Adrenal Vein Sampling for Identification of Surgically Curable Primary Aldosteronism @DrJunYang @AmarLaurence @WuCent

https://t.co/UfGs1MaSXs

[Matt Bailey @edinburgh_renal]

New review🫶🙌 with @EdinburghBean Salt Sensitivity: Causes, Consequences, and Recent Advances | Hypertension https://t.co/K6HXFeKEe6

[Stanley Chen Cardenas @schencardenas]

New somatic mutation in Primary Aldosteronism. Zinc transporter 1 (ZnT1) gene SLC30A1. Congratulations @adina_turcu and group.
https://t.co/yjX9coRhqj

[Emanuele Monda @MondaEmanuele]

Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality

@NEJM

https://t.co/1mpsQ5IicW

[Gerardo Gamba @gerardo_gamba]

Happy to share this review just published in @ajprenal that covers the history of NCC and the development of knowledge along the years. https://t.co/w1xunPvP4P

[JAMA @JAMA_current]

Editorial: A New Dawn for Aldosterone as a Therapeutic Target in Hypertension https://t.co/j2dQvwQzAM #Hypertension23

[Wanpen Vongpatanasin @DrWanpen]

Happy to share that our paper led by talented IM chief resident @KyleOMalleyMD "Diagnostic performance of the adrenal vein to IVC aldosterone ratio in classifying the subtype of PA" is published in Hypertension Research. @UTSWIMchief @Kazuomi_Kario great journal IF >5 and no OA

[American Journal of Hypertension @amjhypertension]

Attending the excellent Aldosterone session at #Hypertension23?

Check out this State-Of-the-Art review from @AnandVaidya17 and colleagues

https://t.co/y9StnDdbql

[Pierre Delanaye @PStoneOftheYear]

New and old GFR equations: a European perspective https://t.co/pB1H09Mzfb
A little story of estimating GFR...free access

[Frontiers - Physiology @FrontPhysiol]

New Research: Renal K+ retention in physiological circumstances: focus on adaptation of the distal nephron and cross-talk with Na+ transport systems #Physiology https://t.co/krypqE6Sgj

[Rein Et Tubulopathies @et_rein]

Very interesting review in Pharmacology and Therapeutics by Kettritz and Loffing: "Potassium homeostasis–Physiology and Pharmacology in a clinical context."
https://t.co/pL2SJIpeo0

[Emmanuelle Vidal-Petiot @EmmaVP5]

@dguerrot @escardio @sfhta @SebastienRubin @com_SFNDT @SABOURETCardio @AnastasiaSMihai @CCF_cardio @CJNephro @AmarLaurence @Rboulestreau Great summary Dominique 👏